• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchBriacell Therapeutics
    Picture of Briacell Therapeutics logo

    BCTX — Briacell Therapeutics Share News

    $2.900.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $25.27m
    • Enterprise Value
      $1.81m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BCTX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BCTX Dividends
    • BriaCell Therapeutics rises on preparatory work for breast cancer therapy trial

      07/04/2022 15:07
    • Brief: Briacell Adds Two Clinical Trial Sites To Accelerate Patient Enrollment

      28/02/2022 13:56
    • BriaCell rises as co begins enrollment for breast cancer treatment trial

      14/07/2021 13:01
    • U.S. STOCKS ON THE MOVE-Blue Apron, Amazon, Oracle, Biogen

      16/06/2021 20:29
    • Brief: Briacell Therapeutics Corp Files For Offering Of Up To 10.34 Million Common Shares By The Selling Shareholders - SEC Filing

      15/06/2021 12:03
    • U.S. STOCKS ON THE MOVE-Biogen, Broadcom, GM, gold miners

      04/06/2021 17:12
    • NASDAQ RESUMED AT 11:08 AM

      03/06/2021 16:08
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:03 AM

      03/06/2021 16:03
    • NASDAQ RESUMED AT 10:58 AM

      03/06/2021 15:58
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:48 AM

      03/06/2021 15:48
    • NASDAQ TRADE HALT HALT NEWS PENDING AT 07:54 AM

      03/06/2021 12:54
    • U.S. STOCKS ON THE MOVE-Cinemark, Tesla, AMC, Blackberry

      02/06/2021 14:01
    • BriaCell Therapeutics: Jumps as lead drug helps control disease across trials

      12/04/2021 13:23
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.